NCT00316030View on ClinicalTrials.gov

Study of Bexarotene in Patients With Acute Myeloid Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 31, 2004

Conditions
AMLAcute Myeloid Leukemia
Interventions
DRUG

Bexarotene

Trial Locations (1)

19104

Abramson Cancer Center of University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT00316030 - Study of Bexarotene in Patients With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter